Istradefylline 40 mg/day enhanced peak levels and AUC of CYP3A4 substrates in clinical trials. This impact wasn't noticed with istradefylline twenty mg/day. Contemplate dose reduction of delicate CYP3A4 substrates.Tolerance to estazolam may well establish from ongoing therapy. Tolerance is often a physiological condition characterized by a lowered